Data gathered: June 30
AI Stock Analysis - ANI Pharmaceuticals (ANIP)
Analysis generated October 6, 2024. Powered by Chat GPT.
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. The company's capabilities include product development, manufacturing, and marketing, with an emphasis on niche markets and high-barrier to entry products. ANI Pharmaceuticals is headquartered in Baudette, Minnesota.
Stock Alerts - ANI Pharmaceuticals (ANIP)
 |
ANI Pharmaceuticals | June 17 Insider Alert: Cook Meredith is selling shares |
|
ANI Pharmaceuticals | June 10 Business Outlook among employees is up by 9.1% over the last month. |
|
ANI Pharmaceuticals | May 17 Insider Alert: Gutwerg Ori is selling shares |
|
ANI Pharmaceuticals | May 16 Insider Alert: Mutz Christopher is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for ANI Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 19 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 17 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 63 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,103 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 60 | Sign up | Sign up | Sign up |
| Linkedin Employees | 564 | Sign up | Sign up | Sign up |
About ANI Pharmaceuticals
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.
| Price | $65.25 |
| Target Price | Sign up |
| Volume | 394,110 |
| Market Cap | $1.42B |
| Year Range | $53.35 - $72.95 |
| Dividend Yield | 0% |
| PE Ratio | 49.06 |
| Analyst Rating | 75% buy |
| Industry | Biotechnology |
In the news
ANI Pharmaceuticals, Inc.(NasdaqGM: ANIP) dropped from Russell 2000 Value IndexJune 29 - Finnhub |
|
ANI Pharmaceuticals, Inc.(NasdaqGM: ANIP) dropped from Russell 3000E Value IndexJune 29 - Finnhub |
|
 |
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives $80.13 Average PT from BrokeragesJune 22 - ETF Daily News |
 |
ANI Pharmaceuticals (NASDAQ:ANIP) Q1 Earnings: Leading The Generic Pharmaceuticals PackJune 19 - Yahoo |
|
Assenagon Asset Management S.A. Decreases Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)June 15 - ETF Daily News |
ANI Pharmaceuticals Announces Presentation of New Preclinical DataJune 12 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 197M | 73M | 124M | 16M | 37M | 0.690 |
| Q4 '24 | 191M | 80M | 110M | -10M | 15M | -0.550 |
| Q3 '24 | 148M | 63M | 85M | -24M | -13M | 1.340 |
| Q2 '24 | 138M | 72M | 66M | -2.3M | 24M | 1.020 |
| Q1 '24 | 137M | 64M | 74M | 18M | 30M | 1.210 |
Insider Transactions View All
| Cook Meredith filed to sell 79,345 shares at $61.4. June 16 '25 |
| Gutwerg Ori filed to sell 89,897 shares at $60.1. May 16 '25 |
| Mutz Christopher filed to sell 107,317 shares at $60.5. May 15 '25 |
| Cook Meredith filed to sell 79,745 shares at $62.2. May 13 '25 |
| Shanmugam Muthusamy filed to sell 631,920 shares at $76.8. May 13 '25 |
Similar companies
Read more about ANI Pharmaceuticals (ANIP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of ANI Pharmaceuticals?
The Market Cap of ANI Pharmaceuticals is $1.42B.
What is ANI Pharmaceuticals' PE Ratio?
As of today, ANI Pharmaceuticals' PE (Price to Earnings) ratio is 49.06.
What is the current stock price of ANI Pharmaceuticals?
Currently, the price of one share of ANI Pharmaceuticals stock is $65.25.
How can I analyze the ANIP stock price chart for investment decisions?
The ANIP stock price chart above provides a comprehensive visual representation of ANI Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ANI Pharmaceuticals shares. Our platform offers an up-to-date ANIP stock price chart, along with technical data analysis and alternative data insights.
Does ANIP offer dividends to its shareholders?
As of our latest update, ANI Pharmaceuticals (ANIP) does not offer dividends to its shareholders. Investors interested in ANI Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of ANI Pharmaceuticals?
Some of the similar stocks of ANI Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.